9 research outputs found
Efficient Synthesis of Empagliflozin, an Inhibitor of SGLT-2, Utilizing an AlCl<sub>3</sub>‑Promoted Silane Reduction of a β‑Glycopyranoside
An efficient production synthesis of the SGLT-2 inhibitor Empagliflozin
(<b>5</b>) from acid <b>1</b> is described. The key tactical
stage involves I/Mg exchange of aryl iodide <b>2</b> followed
by addition to glucono lactone <b>3</b> in THF. Subsequent in
situ treatment of the resulting lactol with HCl in MeOH produces β-anomeric
methyl glycopyranoside <b>4</b> which is, without isolation,
directly reduced with Et<sub>3</sub>SiH mediated by AlCl<sub>3</sub> as a Lewis acid in CH<sub>2</sub>Cl<sub>2</sub>/MeCN to afford <b>5</b> in 50% overall yield. The process was implemented for production
on a metric ton scale for commercial launch
Zinc Catalyzed and Mediated Asymmetric Propargylation of Trifluoromethyl Ketones with a Propargyl Boronate
The development of zinc-mediated
and -catalyzed asymmetric propargylations
of trifluoromethyl ketones with a propargyl borolane and the <i>N</i>-isopropyl-l-proline ligand is presented. The
methodology provided moderate to high stereoselectivity and was successfully
applied on a multikilogram scale for the synthesis of the Glucocorticoid
agonist <b>BI 653048</b>. A mechanism for the boron–zinc
exchange with a propargyl borolane is proposed and supported by modeling
at the density functional level of theory. A water acceleration effect
on the zinc-catalyzed propargylation was discovered, which enabled
a catalytic process to be achieved. Reaction progress analysis supports
a predominately rate limiting exchange for the zinc-catalyzed propargylation.
A catalytic amount of water is proposed to generate an intermediate
that catalyzes the exchange, thereby facilitating the reaction with
trifluoromethyl ketones
Development of a Large Scale Asymmetric Synthesis of the Glucocorticoid Agonist BI 653048 BS H<sub>3</sub>PO<sub>4</sub>
The
development of a large scale synthesis of the glucocorticoid agonist
BI 653048 BS H<sub>3</sub>PO<sub>4</sub> (<b>1·H</b><sub><b>3</b></sub><b>PO</b><sub><b>4</b></sub>) is
presented. A key trifluoromethyl ketone intermediate <b>22</b> containing an <i>N</i>-(4-methoxyphenyl)Âethyl amide was
prepared by an enolization/bromine–magnesium exchange/electrophile
trapping reaction. A nonselective propargylation of trifluoromethyl
ketone <b>22</b> gave the desired diastereomer in 32% yield
and with dr = 98:2 from a 1:1 diastereomeric mixture after crystallization.
Subsequently, an asymmetric propargylation was developed which provided
the desired diastereomer in 4:1 diastereoselectivity and 75% yield
with dr = 99:1 after crystallization. The azaindole moiety was efficiently
installed by a one-pot cross coupling/indolization reaction. An efficient
deprotection of the 4-methoxyphenethyl group was developed using H<sub>3</sub>PO<sub>4</sub>/anisole to produce the anisole solvate of the
API in high yield and purity. The final form, a phosphoric acid cocrystal,
was produced in high yield and purity and with consistent control
of particle size
Development of a Large Scale Asymmetric Synthesis of the Glucocorticoid Agonist BI 653048 BS H<sub>3</sub>PO<sub>4</sub>
The
development of a large scale synthesis of the glucocorticoid agonist
BI 653048 BS H<sub>3</sub>PO<sub>4</sub> (<b>1·H</b><sub><b>3</b></sub><b>PO</b><sub><b>4</b></sub>) is
presented. A key trifluoromethyl ketone intermediate <b>22</b> containing an <i>N</i>-(4-methoxyphenyl)Âethyl amide was
prepared by an enolization/bromine–magnesium exchange/electrophile
trapping reaction. A nonselective propargylation of trifluoromethyl
ketone <b>22</b> gave the desired diastereomer in 32% yield
and with dr = 98:2 from a 1:1 diastereomeric mixture after crystallization.
Subsequently, an asymmetric propargylation was developed which provided
the desired diastereomer in 4:1 diastereoselectivity and 75% yield
with dr = 99:1 after crystallization. The azaindole moiety was efficiently
installed by a one-pot cross coupling/indolization reaction. An efficient
deprotection of the 4-methoxyphenethyl group was developed using H<sub>3</sub>PO<sub>4</sub>/anisole to produce the anisole solvate of the
API in high yield and purity. The final form, a phosphoric acid cocrystal,
was produced in high yield and purity and with consistent control
of particle size
Development of a Scalable, Chromatography-Free Synthesis of <i>t</i>‑Bu-SMS-Phos and Application to the Synthesis of an Important Chiral CF<sub>3</sub>‑Alcohol Derivative with High Enantioselectivity Using Rh-Catalyzed Asymmetric Hydrogenation
A chromatography-free,
asymmetric synthesis of the C2-symmetric
P-chiral diphosphine <i>t</i>-Bu-SMS-Phos was developed
using a chiral auxiliary-based approach in five steps from the chiral
auxiliary in 36% overall yield. Separtion and recovery of the auxiliary
were achieved with good yield (97%) to enable recycling of the chiral
auxiliary. An air-stable crystalline form of the final ligand was
identified to enable isolation of the final ligand by crystallization
to avoid chromatography. This synthetic route was applied to prepare
up to 4 kg of the final ligand. The utility of this material was demonstrated
in the asymmetric hydrogenation of trifluoromethyl vinyl acetate at
0.1 mol % Rh loading to access a surrogate for the pharmaceutically
relavent chiral trifluoroisopropanol fragment in excellent yield and
enantiomeric excess (98.6%)
Process Development of the BACE Inhibitors BI 1147560 BS and BI 1181181 MZ
The development of large-scale syntheses of two beta-site
amyloid
precursor protein cleaving enzyme (BACE) inhibitors is described.
New methodologies were discovered to overcome safety and scalability
problems with existing procedures. The sterically hindered quaternary,
neopentyl stereocenter was formed in high diastereoselectivity by
the addition of a carbamoyl anion to an N-sulfinyl
ketimine. An aryl nitrile was installed by a palladium- and cyanide-free
electrophilic cyanation affected by transnitrilation of an arylmagnesium
derivative with dimethylmalononitrile. A safe route to an oxetanylmethylamine
side chain was devised based on diethyl malonate and dibenzylamine
starting materials. A mild enamine fluorination was developed for
the synthesis of a fluoroisobutylamine side chain
Process Development of the BACE Inhibitors BI 1147560 BS and BI 1181181 MZ
The development of large-scale syntheses of two beta-site
amyloid
precursor protein cleaving enzyme (BACE) inhibitors is described.
New methodologies were discovered to overcome safety and scalability
problems with existing procedures. The sterically hindered quaternary,
neopentyl stereocenter was formed in high diastereoselectivity by
the addition of a carbamoyl anion to an N-sulfinyl
ketimine. An aryl nitrile was installed by a palladium- and cyanide-free
electrophilic cyanation affected by transnitrilation of an arylmagnesium
derivative with dimethylmalononitrile. A safe route to an oxetanylmethylamine
side chain was devised based on diethyl malonate and dibenzylamine
starting materials. A mild enamine fluorination was developed for
the synthesis of a fluoroisobutylamine side chain
Process Development of the BACE Inhibitors BI 1147560 BS and BI 1181181 MZ
The development of large-scale syntheses of two beta-site
amyloid
precursor protein cleaving enzyme (BACE) inhibitors is described.
New methodologies were discovered to overcome safety and scalability
problems with existing procedures. The sterically hindered quaternary,
neopentyl stereocenter was formed in high diastereoselectivity by
the addition of a carbamoyl anion to an N-sulfinyl
ketimine. An aryl nitrile was installed by a palladium- and cyanide-free
electrophilic cyanation affected by transnitrilation of an arylmagnesium
derivative with dimethylmalononitrile. A safe route to an oxetanylmethylamine
side chain was devised based on diethyl malonate and dibenzylamine
starting materials. A mild enamine fluorination was developed for
the synthesis of a fluoroisobutylamine side chain
Process Development of the BACE Inhibitors BI 1147560 BS and BI 1181181 MZ
The development of large-scale syntheses of two beta-site
amyloid
precursor protein cleaving enzyme (BACE) inhibitors is described.
New methodologies were discovered to overcome safety and scalability
problems with existing procedures. The sterically hindered quaternary,
neopentyl stereocenter was formed in high diastereoselectivity by
the addition of a carbamoyl anion to an N-sulfinyl
ketimine. An aryl nitrile was installed by a palladium- and cyanide-free
electrophilic cyanation affected by transnitrilation of an arylmagnesium
derivative with dimethylmalononitrile. A safe route to an oxetanylmethylamine
side chain was devised based on diethyl malonate and dibenzylamine
starting materials. A mild enamine fluorination was developed for
the synthesis of a fluoroisobutylamine side chain